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Abstract: 
Objective: The aim of this study was to determine the prevalence of depression and anxiety in migraine patients. 
Study design: A cross-sectional study. 
Location and duration: In the Psychiatry Department of Mayo hospital Lahore for one year duration from June 
2017 to June 2018. 
Methods: The patient was diagnosed as migraine and headache was included in the analysis. According to the 
designed criteria by International Headache Society the migraine diagnosis was made. Patients were included 
regardless of gender and age. Only subjects who met the inclusion criteria were included. If necessary, routine or 
relevant investigations were conducted. After the subjects were selected, the Depression Scale and Hospital Anxiety 
was applied to the patients. All results were calculated and saved in a designed format. The data were analyzed, 
tabulated and compiled using the 18 version of SPSS. 
Results: 65 women (63.8%) and 37 men (36.2%) were treated with migraine with a minimum age of 11 years and a 
maximum age of 71 years. Most of the patients (76%) are between 21 and 51 years of age. Psychiatric morbidity 
was found in 58 patients (56.8%) using the Urdu-approved version of the Depression Scale and Hospital Anxiety 
with a 11-21 score for depression and anxiety. Therefore, 44 subjects (42.91%) were not recommended for 
psychiatric treatment. From fifty eight patients with positive psychiatric cases, 23 were male and 35 (60%) were 
females. Of these, 25 (43%) had anxiety, 18 (31%) had depression and 15 (27%) had depression and anxiety. Of the 
fifty eight patients receiving psychiatric treatment, 80% were between 21 and 50 years of age. 
Conclusion: Migraine has a strong relationship with depression and anxiety. The prevalence of this association 
may be affected by age and gender. 
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INTRODUCTION: 
Migraine is an episodic disease characterized by 
headache attacks and related symptoms. In Western 
countries, the most common chronic neurological 
disorder is migraine which affects 12% of population. 
It is a heterogeneous condition that results in a 
spectrum of obstacles between different subjects. The 
migraine disability can be serious and can be a 
serious burden for the patient and the community. 
Despite a major disability, migraines are poorly 
recognized, poorly diagnosed and ill-treated. 
Migraine is the result of vascular, electrical and 
neurochemical changes in the nervous system. 
Depression and Anxiety are common in migraine 
affected people and largely remained unnoticed. The 
relationship between various psychiatric, migraine 
and somatic conditions has been reported in the 
researches. In all age groups, migraine has been 
observed but more frequently it is between 25 and 55 
years of age. In all ethnic groups, It has been widely 
noticed. The relationship between migraine, anxiety 
and depression has been systematically reported. 
Women with migraine had high levels of anxiety 
(70%) and depression (52%). Shehbaz N et al. A high 
depression prevalence was reported in the selected 
subjects. Most studies on population-based have 
shown a relationship between migraine and major 
depression. These may show a indirect or direct 
etiological effect of one condition on another. Several 
analysis have been performed globally to know the 
prevalence of depression and anxiety in migraine 
affected patients. For this purpose, various scales can 
be used but the findings of the analysis may not be 
compared to others. This rely on the work design and 
the environment. In this study, we used the Urdu 
version of HADS (Depression Scale and Hospital 
Anxiety). The HADS Urdu version was also used in 
other locally conducted analysis. This standardized 
scale facilitates the identification of psychiatric 
problems in our region. The aim of this analysis was 
to know the prevalence of depression and anxiety in 
migraine patients locally. 
 
MATERIALS AND METHODS: 
This cross-sectional study was held in the Psychiatry 
Department of Mayo hospital Lahore for one year 
duration from June 2017 to June 2018. The patient 
presented with headache after informed consent and 
the demographic information was saved in a special 
form designed for this purpose. A detailed date and 
revision were made. The migraine diagnosis is rely 
on the migraine criteria designed by the IHS. 
Necessary routine and necessary investigations were 
carried out when necessary. Patients were included 
regardless of gender and age. Patients with any other 
surgical or medical problems were excluded from the 
analysis. Patients receiving antidepressants or 
anxiolytic were also discarded. Only migraine 
patients who could complete the Urdu form on their 
own were selected. Hospital Anxiety and Depression 
Scale was applied to the patients. Based on the 
interpretation of the HADS score of Snaith and 
Zigmond, a cut-off value of 11-21 was used to detect 
both depression and anxiety. All results were saved in 
a designed format. Using SPSS 18 version data were 
tabulated, analyzed and compiled. 
 
RESULTS: 
102 total patients with migraine included in the study 
with 64 women (64.08%) and 38 men (35.92%). 11 
years was the minimum age, the highest age was 71 
years and the mean age was 36.91 ± 9.04 years. Table 
1 shows the differentiation of these patients 
according to their age. The maximum number of 
patients (34) (33.3%) was between 40-49 years of 
age. Most of the patients (76%) may be between 21 
and 51 years of age (Table I). 
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Psychiatric morbidity, psychiatric dependence, Urdu 
Anxiety Scale and Hospital Depression were used in 
anxiety and depression in 58 patients (56.8%) with a 
cut-off value of 11-21. The remaining 44 patients 
(43.1%) had no psychiatric problems. Of the 58 
patients with positive psychiatric evaluation, 23 
(40%) and 35 (60%) were male (Table II). 
 
Of these, 25 (43%) had anxiety, 18 (31%) had 
depression and 15 (26%) had anxiety and depression. 
There were 65 patients with migraine, 35 (53.85%) 
comorbidity, 37 male migraine, and 23 (62.16%) 
comorbidity. Among the migraine patients suffering 
from anxiety, 60% (15/25) and 40% (10/25) were 
female. Of the patients with depression, 12/18 
(66.6%) had 6/18 men and 32.93% women. Of the 
patients with depression and anxiety, 7-15 were men 
(46.6%), and 8 women (15.3%) (52.93%) (Table III). 
 
The patients distribution of age with migraine with psychiatric treatment is presented in Table IV. 
 
It can be seen that 81% (57) of patients with positive psychiatric disease are between 21 and 51 years of age. 
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DISCUSSION: 
Clinical findings of migraine are variable in a wide 
range of presentations. Migraine is the result of and 
vascular, electrical and neurochemical changes in the 
nervous system. Depression and Anxiety are common 
in people with migraine and largely remained 
unnoticed. The relationship between migraine and 
various psychiatric and somatic conditions has been 
reported in the literature. Several studies have been 
performed globally to know the prevalence of 
depression and anxiety in migraine patients. In this 
study, we used the Urdu version of HADS. The 
HADS benefit as a diagnostic tool in a local 
psychiatric setting has been confirmed. 102 total 
patients with migraine included in the study with 64 
women (64.08%) and 38 men (35.92%). 11 years was 
the minimum age, the highest age was 71 years and 
the mean age was 36.91 ± 9.04 years. Table 1 shows 
the differentiation of these patients according to their 
age. The maximum number of patients (34) (33.3%) 
was between 40-49 years of age. Most of the patients 
(76%) may be between 21 and 51 years of age. 
Therefore, the prevalence of psychiatric comfort was 
higher in males than in others. Other employees 
reported higher prevalence in women. but; The 
results may differ from one analysis to another 
depending on the study design, clinical setting, 
population studied and sample size. The prevalence 
of psychiatric morbidity, reported as panic disorder, 
is higher in men than in women suffering from 
migraine. Therefore, the increase in the frequency of 
psychiatric morbidity in men supports our study 
results. Therefore, any sexual superiority may not be 
known. Most of the migraine patients (76%) were 
between 20 and 51 years. In the 25-50 age group, 
Migraine was commonly observed. In this study, 
approximately 80% of patients with anxiety and 
depression were between 20 and 50 years of age. On 
the other hand, these data appear to be close to 
previous studies. It is easy to understand that 
depression and anxiety have a strong relationship 
with migraine. The prevalence of depression and 
anxiety in our analysis was 57%. Of these, 25 (43%) 
had anxiety, 18 (31%) had depression and 15 (26%) 
had anxiety and depression. Workers from around the 
world gave information to the association in a 
systematic way. Breslau et al found that in addition, 
migraine patients were found to be more prone to 
affective disorders such as major depression. Shehbaz 
N and colleagues also reported high depression rates 
in patients of migraine, because 41% of patients 
reported depression in their studies. Therefore, 
affective disorders are often found as comorbidity in 
migraine patients. As reflected in the results of our 
study, this situation is similar in this part of the 
world.  
 
CONCLUSION: 
From the study, it can be suggested that migraine has 
a strong relationship with depression and anxiety. 
The prevalence of this relationship may be affected 
by age and gender. In this context, it is necessary to 
study in larger samples. Common headache may 
cause anxiety, impaired quality of life and 
depression. Therefore, such subjects should be 
checked for the psychological disorders presence. 
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